Salarius Pharmaceuticals, Inc. is a clinical-stage oncology company, which engages in the development of treatments for cancers with high, unmet medical need. Its pipeline includes SP-3164, a targeted protein degrader and seclidemstat (SP-2577), a targeted protein inhibitor. The company was founded in February 2014 and is headquartered in Houston, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
2
Frequently Asked Questions
What is Market Cap of Salarius Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Salarius Pharmaceuticals Inc market cap is $2.7M.
What is the 52-week high for Salarius Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Salarius Pharmaceuticals Inc 52 week high is $108.00 as of September 15, 2025.
What is the 52-week low for Salarius Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Salarius Pharmaceuticals Inc 52 week low is $4.50 as of September 15, 2025.
What is Salarius Pharmaceuticals Inc stock price today?
Salarius Pharmaceuticals Inc stock price today is $5.30.
What was Salarius Pharmaceuticals Inc stock price yesterday?
Salarius Pharmaceuticals Inc stock price yesterday was $5.29.
What is the PE ratio of Salarius Pharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Salarius Pharmaceuticals Inc’s P/E ratio is -0.11.
What is the Price-to-Book ratio of Salarius Pharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Salarius Pharmaceuticals Inc P/B ratio is -0.9042.
What is the 50-day moving average of Salarius Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Salarius Pharmaceuticals Inc 50-day moving average is $8.23.
How many employess does Salarius Pharmaceuticals Inc has?
